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Background: There is increasing research that examines gender-issues in multiple sclerosis (MS), but little focus has
been placed on gender-issues regarding physical activity. The aim of the present study was to describe levels of
physical activity, self-efficacy for physical activity, fall-related self-efficacy, social support for physical activity, fatigue
levels and the impact of MS on daily life, in addition to investigating gender differences.
Methods: The sample for this cross-sectional cohort study consisted of 287 (84 men; 29.3%) adults with MS
recruited from the Swedish Multiple Sclerosis Registry. A questionnaire was sent to the subjects consisting of the
self-administrated measurements: Physical Activity Disability Survey – Revised, Exercise Self-Efficacy Scale,
Falls- Efficacy Scale (Swedish version), Social Influences on Physical Activity, Fatigue Severity Scale and Multiple
Sclerosis Impact Scale. Response rate was 58.2%.
Results: Men were less physically active, had lower self-efficacy for physical activity and lower fall-related self-efficacy
than women. This was explained by men being more physically affected by the disease. Men also received less social
support for physical activity from family members. The level of fatigue and psychological consequences of the disease
were similar between the genders in the total sample, but subgroups of women with moderate MS and relapsing
remitting MS experienced more fatigue than men.
Conclusions: Men were less physically active, probably a result of being more physically affected by the disease. Men
being more physically affected explained most of the gender differences found in this study. However, the number of
men in the subgroup analyses was small and more research is needed. A gender perspective should be considered in
strategies for promoting physical activity in subjects with MS, e.g. men may need more support to be physically active.
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The incidence and prevalence of multiple sclerosis
(MS) has increased over the past decades, particularly
among women [1]. The prevalence in Sweden is cur-
rently 188.9/100 000 [2] and about 75% debut between
20–40 years of age [3]. MS is a heterogeneous progres-
sive neurological disorder with consequences such as
muscle weakness, loss of balance, limited sensation, fa-
tigue, and spasticity that can limit a person’s ability to be
physically active [3]. MS is a demyelinating disease of
the central nervous system, and the demyelinated areas
are characterized by inflammation [4]. Physical inactivity* Correspondence: karin.hellstrom@neuro.uu.se
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reproduction in any medium, provided the orin subjects with MS can lead to deterioration in physical
function and increased risk of secondary illness such as
cardiovascular co-morbidities [5,6]. Physical activity can
be defined as all bodily movement that derives from the
contraction of the skeletal muscles and results in in-
creased energy expenditure [7]. Subjects with MS are
less physically active than the general population [8-10],
and individuals with more severe disease are less physic-
ally active compared to those with a milder disease [11].
Persons with MS have lower accelerometer activity and
step counts, and less time spent in moderate-to vigorous
physical activity than matched controls [9]. Cardiorespi-
ratory exercise capacity was up to 30% lower in persons
with MS than in healthy controls [12]. There is strong
evidence that physical activity has positive effects on
physical and mental health and quality of life [13-15].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Differences between respondents and
non-respondents, number (%), and mean ± SD (range)
Respondents Non-respondents P-value
All, n 287 206
Men, n (%) 84 (29.3%) 61 (29.6%) 0.934
Women, n (%) 203 (70.7%) 145 (70.4%)
Age, years 51.5 ± 13.5 49.0 ± 13.4 0.048*
(19–79) (19–80)
Men, years 52.5 ± 14.5 46.7 ± 14.0 0.018*
(19–79) (19–73)
Women, years 51.0 ± 13.0 49.9 ± 13.0 0.463
(22–79) (22–80)
*p < 0.05.
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onstrated in people with MS e.g. muscle strength, aer-
obic capacity, mobility, fatigue level, walking, and quality
of life [16-20].
An important facilitator for physical activity, self-
efficacy for physical activity [21,22], has also been ob-
served in subjects with MS [23-25] but not in all samples
[11,26]. Self-efficacy is defined as the conviction that one
can successfully execute the behavior required to produce
a desired outcome and is a central concept in Social Cog-
nitive Theory [27,28]. Another type of self-efficacy is fall-
related self-efficacy, defined as the degree of efficacy (i.e.
self-confidence) to avoid a fall [29]. Fall-related self-
efficacy is relevant in subjects with MS since falling and
fear of falling is often reported [30-32]. Fatigue has also
been found to be a barrier to physical activity in some
studies [23,25] but not in all [11,33]. On the other hand,
social support for physical activity can be a facilitator for
physical activity in subjects with MS [34], however,
contradictory results have been reported [11]. Studies re-
garding facilitators and barriers to physical activity in sub-
jects with MS are still few and not consistent.
In the general population it has been shown that men
have a higher physical activity level than women [35].
Gender differences regarding factors associated with
physical activity have also been shown, such as personal
barriers that have been found to be more important to
women than men [36-38]. A meta analysis [8] of physical
activity in individuals with MS showed combined sam-
ples of women and men to be significantly less physically
active compared to samples of women alone, indicating
that men are less physically active. Jobin et al. [39]
reviewed the literature and summarized gender-related
issues in MS, showing that a benign course of the dis-
ease is more often associated with the female gender,
and the progression is worse for men than for women
when all disease courses are included. On the other
hand men and women experience disabling fatigue with
the same frequency, whereas studies investigating gender
in social support in general show varying results [39].
Little research focus has been placed on gender in MS
with regard to physical activity, despite the gender differ-
ences found in other populations.
Aims
The aim of the study was to examine physical activity,
severity of disease, fatigue levels, self-efficacy for physical
activity, fall-related self-efficacy and social support for
physical activity, in a sample of subjects with MS, in
addition to study gender differences.
Methods
The study has been performed as a cross-sectional co-
hort survey with a descriptive and comparative design.Study cohort
Individuals between 18–80 years with a diagnosis of MS
were recruited from the Swedish Multiple Sclerosis
Registry (http://www.msreg.net). The register specify
four types of MS; relapsing remitting, secondary pro-
gressive, primary progressive or progressive relapsing.
All registered subjects living in the county of Uppsala
were invited to participate (502 subjects). Five subjects
were excluded due to not having the required diagnosis.
Other reasons for exclusion were not living independent
(n = 1), not understanding Swedish (n = 1), having an-
other neurological disease (n = 1), and not being able to
answer the survey (n = 1). The final sample consisted of
287 subjects with MS (response rate 58.2%). In total
there were 84 men (29.3%) and 203 women (70.7%), giv-
ing a female-to-male ratio of 2.42:1. The female-to-male
ratio for the 206 subjects who did not respond to the in-
vitation to participate in the survey was 2.38:1. Non-
respondents were slightly younger than respondents, see
Table 1.
Measurements
For all measurements the Swedish versions of the scales
were used. For this study four measurements (PADS-R,
ACTIVLIM, ESES, SIPA) were translated into Swedish,
since no previous Swedish version existed. The transla-
tion process was following standards mainly from works
by Beaton et al. [40] and Hilton and Skrutkowski [41].
For the other scales previous translations were used.
Primary outcome variables:
Physical activity was measured using the Physical
Activity Disability Survey – Revised (PADS-R) [42].
The PADS-R was developed to measure physical activ-
ity in people with chronic illness and/or disability [43].
The survey includes six subscales; exercise, leisure time
physical activity, general activity, therapy, employment
and wheelchair use. For each scale the amount of
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The ratings from the subscales are summed to give a
total PADS-R score. The higher the score, the higher the
level of physical activity. A high intra-class correlation
coefficient and acceptable limits of agreement are
demonstrated for test-retest reliability [42].
Physical and psychological consequences of disease was
measured using the Multiple Sclerosis Impact Scale
(MSIS-29) [44]. This scale includes 29 questions
regarding the impact of MS on daily life over the
previous two weeks (answers from one = not at all, to
five = extremely). Twenty items concern physical
consequences and nine concern psychological
consequences. Summary scores for each scale are
transformed to a 0–100 scale, where high values
indicate more severe consequences. The scale
demonstrates evidence of validity, high internal
consistency, high reliability and responsiveness [44,45].
The physical scale was used in this study to classify the
participants in four groups, indicating level of disease
impact defined as 0–25 (minimal disease), >25-50 (mild
disease), >50-75 (moderate disease) , >75-100 (severe
disease) [46].
Fatigue was measured with the Fatigue Severity Scale
(FSS) [47,48]. This scale includes nine questions to
identify features of fatigue. Each question has alternative
answers ranging from one (strongly disagree) to seven
(strongly agree), and a total FSS is calculated by taking
the mean of the nine questions. A higher score indicates
a more severe level of fatigue [47]. A FSS score ≥4 can be
used as a cut-off score for the presence of fatigue [49].
The English and the Swedish versions have been found
to be reliable and valid [47,48].
Self-efficacy for physical activity was measured using
the Exercise Self-Efficacy Scale (ESES) [50]. This scale
includes 10 items concerning confidence when carrying
out regular physical activities and exercise. Each item
has four answer options (1 = not at all true, 2 = rarely
true, 3 = moderately true, 4 = always true). The scores
are summed to yield a total score (maximum 40 p).
A high score indicates higher exercise self-efficacy.
High internal consistency, good scale integrity and
satisfactory content validity have been shown [50].
Fall-related self-efficacy was measured using the Falls
Efficacy Scale (Swedish version) (FES(S)) [51]. The
original scale measures the degree of confidence to
performing 10 common daily activities without falling
[29]. In the Swedish version three additional items are
included [51] The items are graded on a visual scale
from not confident at all (0) to completely confident(10). The FES(S) is divided into two subscales 1)
Personal Activities of Daily Living (PADL), items 1–6
and 2) Instrumental Activities of Daily Living (IADL)
items 8–13. Item no. 7 (walking up and down stairs) is
regarded as a transitory item. All items can be summed
to yield a total score (maximum 130 p). A high score
indicates higher self-efficacy. The use of FES(S) has
shown high test-retest reliability and has also been
found to be responsive to changes [52].
Social support for physical activity was measured using
Social Influences on Physical Activity (SIPA) [53]. This
is a multidimensional scale and includes social support
i.e. positive social influence (SIPApos) and negative
social influences (SIPAneg) [53]. SIPApos includes
questions on dimensions of companionship,
informational and esteem support whereas SIPAneg
includes questions on inhibitive, justifying and
criticizing behaviour [53]. A 5-point scale (from 0 = never
to 4 = very often) is used to measure the occurrence of
social influences over the last 12 months. For each item
the influences of three different sources are estimated;
family, friends and experts. The scale includes 27 items,
where 12 items measure negative social influence and 15
measure positive social influences. For each subscale the
results for family/friends/experts can be calculated as the
sum of all items divided by 12 (SIPAneg) and 15 (SIPApos).
A total result for the subscales can also be calculated as
the sum of all items for family/friend/experts divided by 36
(SIPAneg) and 45 (SIPApos). Evidence of content validity
and reliability has been shown [53,54].
Secondary and background variables were also assessed.
Activity limitation was measured using the ACTIVLIM
questionnaire (www.rehab-scales.org) [55]. Activity
limitations are defined as difficulties a person might
have in executing activities of daily living. The part of
the questionnaire for adults consists of 18 daily
activities. Each question has four answer alternatives;
impossible, difficult, easy and question mark (difficulty
cannot be estimated since the activity has never been
tried). The total score for the questionnaire is
expressed in logits. A high score corresponds to a high
activity level. The questionnaire exhibits very good
psychometric qualities, including reliability, construct
validity, reproducibility, linearity and unidimensionality
[55] and has a good sensitivity to change [56].
Gait ability was estimated by the questions “Can you
walk?” and “How far can you walk outside during the
summertime?”
A yes or no question on fear of falling was also in-
cluded (“Are you afraid of falling?”).
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garding other health problems. From the open question,
the Functional Comorbidity Index (FCI) [57] was used
afterwards by the first author to count number of co-
morbidities. FCI was developed with physical function as
the outcome. This has shown stronger association with
physical function than Charlson and Kaplan-Feinstein
indices, and FCI correctly classified patients into high
and low function groups in 77% of cases [57]. Body Mass
Index (BMI) was calculated by dividing body weight by
height squared (kg/m2) [58].
Procedure
After review of the Swedish population register for the
addresses of eligible participants, a questionnaire was
sent out by surface mail. An informatory letter, a written
consent form, and a stamped reply envelope were in-
cluded with the questionnaire. The self-assessment ques-
tionnaire was divided in two parts, due to the length of
the questionnaire, with the second part sent out two
weeks after a reply with answers to the first part of the
questionnaire was received. The first part consisted of
questions about consequences of MS, activity limitation,
physical activity and background questions. The second
part included questions on self-efficacy and social sup-
port for physical activity, fall-related self-efficacy, fatigue
and gait. Two reminders were sent to subjects who did
not answer either of the parts in three weeks. All partici-
pants in the study provided written informed consent to
participate. The study was approved by the Regional
Ethical Review Board, Uppsala, Sweden, D-no 2010/278.
Statistical methods
Data was analyzed using SPSS (Statistical Package for
Social Sciences, version 20). Missing values for occa-
sional data in scales with ordinal questions were im-
puted with median for the appropriate subscale when
the level of missing data was <33% of the subscale.
When the amount of missing data was ≥33% the total
of the scale was not calculated. For the different mea-
sures this was the case in six MSIS-29 physical and
psychological, two FSS, one ACTIVLIM and PADS-R,
three ESES, four FES(S), eight SIPAneg and 13 SIPA-
pos cases i.e. 4.5% at most. In a few cases (3,4) height
and weight were missing. These values were imputed
by the mean for men or women. Subgroup analyses
were performed to explore if the gender differences
were caused by the men being more severely affected
by the disease. The subgroup analyses focused on
physical consequences of disease (MSIS-29 physical
scale) and type of MS. After checks of normal distri-
bution differences between men and women were ana-
lyzed with Chi-square test, Mann–Whitney U-test or
Student’s t-test depending on the type of scale andnormal distribution. The level of significance was set
at p < 0.05.
Results
Background characteristics and secondary outcome mea-
sures are presented in Table 2. The mean age of the
study cohort was 51.5 ± 13.5 years, and the median time
since diagnosis was 11 years. Type of MS was relapsing
remitting or secondary progressive in 83% of the sub-
jects. No differences between the genders were found for
most of the background variables except that the men
had been diagnosed for a significantly longer time. Men
were more limited in their activity and walked shorter
distances outdoors (Table 2). In addition, 20.2% men
versus 6.4% women were not able to walk.
The primary outcome measures are presented in
Table 3. The mean physical activity level was 0.184 ±
1.475. Physical activity levels were lower in men, and
65.5% of the men versus 47.8% of the women had an
activity level less than the mean value. The median
physical and psychological consequences of the disease
(MSIS-29) were 27.5 and 27.8 respectively. Men were
more physically affected than women with a median
physical value of 41.3 versus 25.0 for women, p = 0.004.
Severe disease was found in 17.9% of the men and 5.4%
of the women. Fatigue and psychological consequences
of the disease were similar between the genders. The
medians for self-efficacy for physical activity and fall-
related self-efficacy were 27 and 112 respectively for
the whole sample with significant gender differences.
Men had significantly lower physical activity self-
efficacy (ESES) and fall-related self-efficacy (FES(S))
compared to women. Social support for physical activ-
ity was similar between the genders, despite the finding
that men received less positive support from family
compared to women.
Physical consequences of disease subgroup analyses
(MSIS-29 physical scale) showed that the differences be-
tween the genders found in the whole sample disappeared.
But another difference emerged; women with moderate
MS experienced higher level of fatigue than men (Table 4).
Women with relapsing remitting MS experienced
higher level of fatigue than men. Men with secondary
progressive MS were less physically active than the
women, which might be explained by the more severe
physical consequences of the disease (Table 5).
Discussion
Our results showed, in a Swedish sample of subjects
with MS, that men were less physically active, had lower
levels of self-efficacy for physical activity and fall-related
self-efficacy, and received less social support from fam-
ily. These gender differences were explained by men
being more physically affected by the disease. The
Table 2 Background characteristics, and secondary outcome measures, mean ± SD (range), median (IQ-range), or
number (%)
All Men Women P-value
Age (years) 51.5 ± 13.5 (19–79) 52.5 ± 14.5 (19–79) 51.0 ± 13.0 (22–79) 0.397
Type of MS relapsing remitting 135 (47.0%) 26 (31.0%) 109 (53.7%) 0.450
secondary progressive 104 (36.2%) 37 (44.0%) 67 (33.0%)
primary progressive 32 (11.1%) 16 (19.0%) 16 (7.9%)
progressive relapsing 10 (3.5%) 4 (4.8%) 6 (3.0%)
subtype not known 6 (2.1%) 1 (1.2%) 5 (2.5%)
Time since diagnosis (years) 11 (11–18) 12 (7–22) 10 (5–18) 0.027*
Living with partner alone 80 (27.9%) 27 (32.1%) 53 (26.1%) 0.266
with partner 203 (70.7%) 55 (65.5%) 148 (72.9%)
Living with children without children 216 (75.3%) 66 (78.6%) 150 (73.9%) 0.403
with children 71 (24.7%) 18 (21.4%) 53 (26.1%)
Education compulsory school 39 (13.6%) 14 (16.7%) 25 (12.3%) 0.473
upper secondary school 118 (41.1%) 34 (40.5%) 84 (41.1%)
post-secondary school 124 (43.2%) 32 (38.1%) 92 (45.3%)
Work status working 118 (41.1%) 29 (34.5%) 89 (43.8%) 0.398
student 4 (1.4%) 1 (1.2%) 3 (1.5%)
out of work 8 (2.8%) 2 (2.4%) 6 (3.0%)
parental leave 4 (1.4%) 1 (1.2%) 3 (1.5%)
sickness benefit 52 (18.1%) 16 (19.0%) 36 (17.7%)
retired due to age 61 (21.3%) 24 (28.6%) 37 (18.2%)
parttime work/sickness benefit 12 (4.2%) 1 (1.2%) 11 (5.4%)
other 23 (8.0%) 8 (9.5%) 15 (7.4%)
Height (cm) 170.4 ± 8.1 179.0 ± 5.6 166.8 ± 5.9 N.A.
Weight (kg) 71.8 ± 12.2 79.4 ± 11.0 68.7 ± 11.3 N.A.
BMI (kg/m2) 24.7 ± 3.8 24.7 ± 3.0 24.7 ± 4.1 0.926
Smoking yes 41 (14.3%) 12 (14.3%) 29 (14.3%) 0.952
no 243 (84.7%) 70 (83.3%) 173 (85.2%)
Other diseases 0 212 (73.9%) 67 (79.8%) 145 (71.4%) 0.152
1 58 (20.2%) 13 (15.5%) 45 (22.2%)
2 14 (4.9%) 3 (3.6%) 11 (5.4%)
3 3 (1.0%) 1 (1.2%) 2 (1.0%)
ACTIVLIM 3.2 (1.1–6.3) 1.8 (−0.2–6.2) 3.7 (1.5–6.3) 0.002*
Gait Y/N yes can walk 256 (89.2%) 67 (79.8%) 189 (93.1%) 0.001*
no can’t walk 30 (10.5%) 17 (20.2%) 13 (6.4%)
Gait outside† 1–50 m 15 (10.5%) 5 (6.0%) 10 (4.9%) 0.001*
51–100 m 19 (5.2%) 8 (9.5%) 11 (5.4%)
101–500 m 30 (10.5%) 9 (10.7%) 21 (10.3%)
501–1000 m 5 (8.7%) 4 (4.8%) 21 (10.3%)
1001–3000 m 33 (11.5%) 9 (10.7%) 24 (11.8%)
>3000 m 110 (38.3%) 25 (29.8%) 85 (41.9%)
Fear of falling yes 109 (38%) 32 (38.1%) 77 (37.9%) 0.951
no 162 (56.4%) 47 (56.0%) 115 (56.7%)
*p < 0.05, N.A. = not applicable. † = total sum not 100% because those who could not walk are not displayed.
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Table 3 Primary outcome measures, mean ± SD, median (IQ-range), or number (%)
All Men Women P-value
PADS-R total 0.184 ± 1.475 –0.180 ± 1.632 0.333 ± 1.383 0.007*
≥ mean 135 (47.0%) 29 (34.5%) 106 (52.2%) 0.006*
< mean 152 (53.0%) 55 (65.5%) 97 (47.8%)
MSIS-29 physical 27.5 (7.5–52.5) 41.3 (13.8–63.8) 25.0 (6.3–47.5) 0.004*
psychological 27.8 (11.1–47.2) 30.6 (13.9–50.0) 25.0 (9.0–43.8) 0.18
physical 0–25 133 (46.3%) 31 (36.9%) 102 (50.2%) 0.002*
physical >25–50 71 (24.7%) 15 (17.9%) 56 (27.6%)
physical >50–75 51 (17.8%) 20 (23.8%) 31 (15.3%)
physical >75–100 26 (9.1%) 15 (17.9%) 11 (5.4%)
FSS total 4.66 (2.94–5.89) 4.78 (3.11–6.11) 4.56 (2.9–5.89) 0.417
≥4 177 (61.7%) 54 (64.3%) 123 (60.6%) 0.51
<4 108 (37.6%) 29 (34.5%) 79 (38.9%)
ESES 27 (20–35) 25 (18–33) 28 (21–36) 0.013*
FES(S) total 112 (65–129) 99 (40–128) 116 (76–130) 0.012*
IADL 52 (26–60) 41 (12–60) 54 (29–60) 0.016*
PADL 54 (36–60) 51 (25–59) 56 (42–60) 0.003*
SIPAneg total 0.06 (0.00–0.28) 0.08 (0.00–0.33) 0.06 (0.00–0.25) 0.067
family 0.08 (0.00–0.33) 0.13 (0.00–0.58) 0.08 (0.00–0.33) 0.558
friends 0.00 (0.00–0.33) 0.08 (0.00–0.33) 0.00 (0.00–0.33) 0.454
experts 0.00 (0.00–0.08) 0.00 (0.00–0.17) 0.00 (0.00–0.08) 0.215
SIPApos total 0.80 (0.40–1.36) 0.73 (0.36–1.25) 0.82 (0.40–1.38) 0.382
family 1.13 (0.45–1.75) 1.00 (0.55–1.70) 1.23 (0.40–1.80) 0.005*
friends 0.67 (0.20–1.40) 0.60 (0.08–1.07) 0.80 (0.27–1.47) 0.139
experts 0.23 (0.00–1.15) 0.40 (0.00–1.25) 0.20 (0.00–1.07) 0.38
*p < 0.05, MSIS-29 = Multiple Sclerosis Impact Scale, FSS = Fatigue Severity Scale, PADS-R = Physical Activity Disability Survey – Revised, ESES = SCI Exercise Self-
Efficacy Scale, FES(S) = Falls Efficacy Scale Swedish version, IADL = Instrumental Activities of Daily Living, PADL = Personal Activities of Daily Living, SIPAneg = Social
Influences on Physical Activity negative subscale, SIPApos = Social Influences on Physical Activity positive subscale.
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between the genders. Subgroup analysis showed that
women with moderate physical consequences of the dis-
ease and women with relapsing remitting MS experi-
enced more fatigue than men.
Physical activity
Men were found to be less physically active, both when
comparing the mean PADS-R value and when splitting
the sample in two groups (≥ mean/< mean). In accord-
ance with our results a meta-analysis by Motl et al. [8]
has shown combined samples of women and men to be
significantly less physically active than samples solely of
women. The lower activity level in men was in our study
explained by them being more physically affected by the
disease. Thus, the genders were equally active when con-
sideration was taken to physical consequences of the dis-
ease. Our results are in accordance with other studies
reporting that MS subjects with more severe disease are
less physically active [11,23].The fact that men and women with MS were equally ac-
tive is in contrast to results from the general population,
where men are more physically active [35]. One explan-
ation might be a gender bias in the measurements used,
i.e. underestimation of physical activity in women, as
many studies have focused on activities associated with
sports and exercise (traditionally performed by men)
and less on activities performed by women, such as
housework, gardening and walking [59]. However, the
PADS-R used in this study measures a wide range of
activities that may better reflect the overall physical ac-
tivity levels in both men and women [60]. All physical
activity is of benefit, but WHO recommends at least
150 min of moderate-intensity aerobic physical activity
throughout the week, but for additional health benefits
this activity should be increased to at least 300 min
[14]. However, it is not known yet which value on the
PADS-R that equivalents this level of physical activity.
The mean physical activity level measured with PADS-
R was 0.184 which is slightly higher than in another
Table 4 Physical consequences of disease subgroup
analysis (MSIS-29 physical scale), mean ± SD, median
(IQ-range)
MSIS-29 0–25, minimal MS
Men (n = 31) Women (n = 102) P-value
PADS-R total 1.213 ± 1.389 1.094 ± 1.063 0.613
FSS total 3.44 (1.78–5.11) 3.39 (2.22–4.58) 0.831
ESES 32 (25–35) 35 (27–40) 0.103
FES(S) total 129 (123–130) 129 (122–130) 0.998
SIPApos family 0.90 (0.33–1.65) 1.27 (0.40–1.82) 0.263
MSIS-29 ≤ 50, minimal and mild MS
Men (n = 46) Women (n = 158) P-value
PADS-R total 0.807 ± 1.442 0.727 ± 1.188 0.704
FSS total 4.00 (2.33–5.36) 4.28 (2.56–5.22) 0.595
ESES 29 (23–35) 30 (23–37) 0.388
FES(S) total 124 (100–130) 125 (103–130) 0.941
SIPApos family 1.00 (0.60–1.57) 1.27 (0.40–1.80) 0.603
MSIS-29 > 50–75, moderate MS
Men (n = 20) Women (n = 31) P-value
PADS-R total −1.031 ± 1.006 −0.843 ± 0.892 0.486
FSS total 5.89 (4.25–6.42) 6.50 (5.57–6.89) 0.047*
ESES 20 (16–29) 22 (16–28) 1.000
FES(S) total 63 (34–87) 48 (29–81) 0.387
SIPApos family 0.93 (0.20–1.47) 1.33 (0.72–1.73) 0.150
MSIS-29 > 50–100, moderate and severe MS
Men (n = 35) Women (n = 42) P-value
PADS-R total −1.332 ± 0.933 −1.147 ± 1.031 0.415
FSS total 6.00 (4.50–6.58) 6.44 (5.50–6.89) 0.193
ESES 18 (13–26) 20 (15–26) 0.542
FES(S) total 41 (10–69) 40 (21–60) 0.935
SIPApos family 1.00 (0.28–1.83) 1.27 (0.57–1.73) 0.528
* p < 0.05, MSIS29 =Multiple Sclerosis Impact Scale, PADS-R = Physical Activity
Disability Survey – Revised, FSS = Fatigue Severity Scale ESES = SCI Exercise
Self-Efficacy Scale, FES(S) = Falls Efficacy Scale Swedish version, SIPApos =
Social Influences on Physical Activity positive subscale.
Table 5 Diagnosis subtype subgroup analysis, mean ± SD,
median (IQ-range)
MS type, relapsing remitting
Men (n = 26) Women (n = 109) P-value
MSIS-29 physical 8.8 (1.3–23.8) 11.3 (2.5–30.0) 0.235
psychological 16.7 (8.3–38.9) 25.0 (8.3–41.7) 0.336
PADS-R total 0.933 ± 1.612 0.840 ± 1.240 0.745
FSS total 3.22 (1.78–5.14) 4.33 (2.89–5.67) 0.048*
ESES 29 (22–39) 32 (26–37) 0.571
FES(S) total 129 (111–130) 128 (111–130) 0.927
SIPApos family 0.97 (0.60–1.55) 1.37 (0.57–1.87) 0.280
MS type, secondary progressive
Men (n = 37) Women (n = 67) P-value
MSIS-29 physical 53.8 (28.8–77.5) 40.0 (23.8–58.8) 0.019*
psychological 33.3 (16.7–47.2) 25.0 (11.1–41.7) 0.346
PADS-R total −0.874 ± 1.266 −0.349 ± 1.241 0.043*
FSS total 5.89 (3.78–6.39) 5.22 (3.44–6.44) 0.390
ESES 24 (18–33) 24 (16–32) 0.981
FES(S) total 66 (31–103) 82 (48–115) 0.289
SIPApos family 0.93 (0.30–1.87) 1.13 (0.27–1.70) 0.784
* p < 0.05, MSIS-29 = Multiple Sclerosis Impact Scale, PADS-R = Physical Activity
Disability Survey – Revised, FSS = Fatigue Severity Scale ESES = SCI Exercise
Self-Efficacy Scale, FES(S) = Falls Efficacy Scale Swedish version, SIPApos =
Social Influences on Physical Activity positive subscale.
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was 0.02 ± 1.32 [25].
Severity of disease and fatigue
In this study a large gender difference was found in the
severity of disease as measured with MSIS-29. Men were
also more limited in their activity and walking ability
than women. Although men experienced significantly
more severe physical consequences of the disease there
were no differences between the genders in psycho-
logical consequences. Subgroup analyses showed that
men with secondary progressive MS were much more
physically affected by the disease, but for relapsing re-
mitting MS no significant differences in consequences ofthe disease, as measured with MSIS-29, were found. This
is in accordance with other studies summarized by Jobin
et al. [39] showing that a benign course of the disease is
more often associated with female gender, and the pro-
gression is worse for men compared to women.
There was no gender difference in fatigue in the whole
sample, but women with relapsing remitting MS, and
moderate MS experienced more fatigue than men (Tables 4
and 5). Previous reports on fatigue in MS are inconclusive
[39,61,62].Self-efficacy for physical activity
Self-efficacy for physical activity was high, which in ac-
cordance with another study in subjects with MS [23].
Men in our study rated self-efficacy for physical activity
lower than women, but this difference was not main-
tained when physical consequences of disease and dis-
ease subtypes were included in the analyses. Thus, the
lower self-efficacy for physical activity in men may be
explained by the more physically affected and less phys-
ically active men. Social support enhances a person’s
level of self-efficacy [27]. Women in our study had sig-
nificantly more social support for physical activity from
family members, which might have contributed to the
higher level of self-efficacy in women.
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We found that fall-related self-efficacy was high in the
total sample, but lower in men compared to women.
Again the gender difference in our data was explained
by men being more affected by the disease. Our data is
in accordance with another study reporting that experi-
encing more MS symptom interference during everyday
activities is associated with fear of falling [31]. The
FES(S) has to our knowledge not been previously used
to examine subjects with MS. The English version has
been used for persons with MS and correlated with bal-
ance parameters and improved after progressive resist-
ance training [18]. The English and Swedish versions
are not equivalent due to the different number and or-
dering of activities.
Social support for physical activity
The most important source of positive influence in our
study and also in previous reports [53,54] was found to
be from family. Women in this sample received more
social support from family than men, but no other gen-
der differences were found for all other positive or nega-
tives influences. However, both subgroups analyses
showed no significant gender differences. A reason for
this could be that the gender difference was rather small,
and only statistically significant in the total sample.
SIPA was chosen to measure social support for physical
activity because it measures both social support and
negative social influences that are considered to be dif-
ferent constructs [54]. In this study the negative influ-
ences were low, which is positive. Some negative
influences were projected to persons with MS from
family members, but were nearly absent from friends
and experts. In this study a large floor effect was found
for the negative social influence subscale, with a mean
of zero for 36.2% of the total and even higher values for
subscales (family 46.0%, friends 51.2%, and experts
69.0%). Due to these findings the future use of this sub-
scale for persons with MS in Sweden cannot be recom-
mended, but a floor effect for SIPApos was only found
for the expert subscale (34.8%).
Generalization and limitations
The Swedish Multiple Sclerosis Registry, from where our
subjects were recruited, is a register where patients with
MS or possible MS have been entered [2], which implies
a risk for inclusion of subjects not actually having the
diagnosis. We found five subjects who did not have the
required diagnosis for inclusion.
In our study the mean age was 51.5 years and the
female-to-male ratio 2.42:1. This is close to the na-
tionwide Swedish MS study (n = 17 485), where the
mean age was 52.6 years and the female-to-male ratio
2.35:1 [2], which strengthen the external validity ofour results and extrapolation to other individuals with
MS in Sweden.
It is important to keep in mind when generalizing our
result that this study sample consisted of persons living
at home with relatively low consequences of MS. The
consequences of disease in our sample were lower than
in two other MS samples where the mean MSIS-29 was
45.5-57.2 on the physical scale and 46.2-67.2 on the psy-
chological scale [45,46]. One reason for the more af-
fected samples in other studies could be the focus on
subjects with more severe MS and more clinical contact
[45,46].
The response rate in this sample cohort was 58.2%.
This is similar to the mean response rate of 60% for
published studies in medical journals [63] and for other
MS studies using mailed surveys (response rates 31-
77% [6,23,25,44,46,61,64]). The response rate itself is
not, however, a sufficient measure of the quality of a
study if there are enough cases for statistical analyses,
although there are more possibilities of non-response
bias [63]. In this study there were enough respondents
for statistical analyses, but a non-response bias was also
found. The non-respondents were younger. One reason
for this could be that younger subjects experienced
fewer symptoms from the disease and considered the
questions not suitable, or perhaps they were even emo-
tionally stressed by questions about subjects such as
symptoms and gait ability.
Poor design of a questionnaire will result in a failure
to measure what is required [65]. In this study mea-
surements with adequate reliability and validity were
used. However, there are some limitations. Four of the
measurements have recently been translated from Eng-
lish into Swedish, and only two of the Swedish transla-
tions have yet been psychometrically tested. ESES
showed satisfying results but there were not enough
subjects to draw conclusions from SIPA (unpublished
results). A strength is however that our research group
did make efforts to perform a thorough process of
translation. Ceiling effects were found for ACTIVLIM
(31.5%) and FES(S) (23.3%) that have not yet been psy-
chometrically evaluated in individuals with MS. The
total questionnaire included many questions. After
pilot-reading of the questionnaire by representatives
from a patient organization, Neuro Sweden, it was de-
cided in discussions with the representatives to separate
the survey into two parts.
Clinical implications
Physical activity behavior to promote health and
minimize secondary complications of inactivity such as
coronary heart disease and type II diabetes [66] should
be emphasized in patients with MS. Persons with low
levels of physical activity need more support from health
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results show that this particularly concerns men, and it
can be explained by them being more physically affected
by the disease. Probably individualized and adapted
physical activity support is of value. It is important for
clinicians to use the family as a resource in patient-
rehabilitation. Some women experience more fatigue
than men, and might need more support from clinicians
to overcome this barrier to physical activity. Our results
are of value in achieving a better understanding of gen-
der differences.
Conclusions
This cohort study of physical activity levels in subjects
with MS in Sweden demonstrated that men were less
physically active, and had lower levels of self-efficacy for
physical activity and fall-related self-efficacy. These gen-
der differences were explained by men being more phys-
ically affected by the disease. The study also identified
that men received less social support from family mem-
bers. Subgroups of women with moderate MS and re-
lapsing remitting MS experienced more fatigue than
men. Few studies have been focusing on gender and
physical activity, and future studies are of value.
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